Drugs / Nephrovit
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03408639 Background | Jun 2016 → Jul 2017 | aregenerative anemia | Cinnagen | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nephrovit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03408639 ↗ |